Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myrtle Davis

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2017
Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical StudiesDane R Liston, Myrtle Davis
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 1, 2015
Human CD34(+) progenitor hematopoiesis in liquid culture for in vitro assessment of drug-induced myelotoxicityLiang Guo, John Hamre, Myrtle Davis, et al.
Scientific Reports|August 28, 2024
Publisher Correction: Lower diastolic tension may be indicative of higher proarrhythmic propensity in failing human cardiomyocytesXin Zhou, Paul Levesque, Khuram Chaudhary, et al.
Current Protocols in Chemical Biology|September 3, 2015
Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling PathwaysLiang Guo, Sandy Eldridge, Mike Furniss, et al.
Scientific Reports|July 29, 2024
Lower diastolic tension may be indicative of higher proarrhythmic propensity in failing human cardiomyocytesXin Zhou, Paul Levesque, Khuram Chaudhary, et al.
Nature Reviews. Clinical Oncology|January 30, 2013
Safety and feasibility of targeted agent combinations in solid tumoursSook Ryun Park, Myrtle Davis, James H Doroshow, et al.
Toxicology and Applied Pharmacology|October 1, 2018
Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitroLiang Guo, Sandy Eldridge, Michael Furniss, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 25, 2014
Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytesSandy Eldridge, Liang Guo, Jodie Mussio, et al.
Scientific Data|January 9, 2019
Transcriptomic profiles of tissues from rats treated with anticancer drug combinationsMyrtle Davis, Elaine Knight, Sandy R Eldridge, et al.
International Journal of Oncology|May 9, 2013
Analyses of the combination of 6-MP and dasatinib in cell cultureGurmeet Kaur, Holger Behrsing, Ralph E Parchment, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2017
Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical StudiesDane R Liston, Myrtle Davis
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 1, 2015
Human CD34(+) progenitor hematopoiesis in liquid culture for in vitro assessment of drug-induced myelotoxicityLiang Guo, John Hamre, Myrtle Davis, et al.
Scientific Reports|August 28, 2024
Publisher Correction: Lower diastolic tension may be indicative of higher proarrhythmic propensity in failing human cardiomyocytesXin Zhou, Paul Levesque, Khuram Chaudhary, et al.
Current Protocols in Chemical Biology|September 3, 2015
Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling PathwaysLiang Guo, Sandy Eldridge, Mike Furniss, et al.
Scientific Reports|July 29, 2024
Lower diastolic tension may be indicative of higher proarrhythmic propensity in failing human cardiomyocytesXin Zhou, Paul Levesque, Khuram Chaudhary, et al.
Nature Reviews. Clinical Oncology|January 30, 2013
Safety and feasibility of targeted agent combinations in solid tumoursSook Ryun Park, Myrtle Davis, James H Doroshow, et al.
Toxicology and Applied Pharmacology|October 1, 2018
Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitroLiang Guo, Sandy Eldridge, Michael Furniss, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 25, 2014
Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytesSandy Eldridge, Liang Guo, Jodie Mussio, et al.
Scientific Data|January 9, 2019
Transcriptomic profiles of tissues from rats treated with anticancer drug combinationsMyrtle Davis, Elaine Knight, Sandy R Eldridge, et al.
International Journal of Oncology|May 9, 2013
Analyses of the combination of 6-MP and dasatinib in cell cultureGurmeet Kaur, Holger Behrsing, Ralph E Parchment, et al.
Pageof 4